HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda.

Ndahimana, Jean d'Amour; Riedel, David J; Muhayimpundu, Ribakare; Nsanzimana, Sabin; Niyibizi, Gad; Mutaganzwa, Emmanuel; Mulindabigwi, Augustin; Baribwira, Cyprien; Kiromera, Athanase; Jagodzinski, Linda L; Peel, Sheila A; Redfield, Robert R

Ndahimana, Jean d'Amour; Riedel, David J; Muhayimpundu, Ribakare; Nsanzimana, Sabin; Niyibizi, Gad; Mutaganzwa, Emmanuel; Mulindabigwi, Augustin; Baribwira, Cyprien; Kiromera, Athanase; Jagodzinski, Linda L; Peel, Sheila A; Redfield, Robert R.

Affiliation

Ndahimana Jd; HIV/AIDS Division, Rwanda Biomedical Center, Kigali, Rwanda.

Antivir Ther ; 21(3): 253-9, 2016.

Article in En | MEDLINE | ID: mdl-26562173

Subject(s)

Anti-HIV Agents/therapeutic use; Drug Resistance, Viral/genetics; HIV Infections/drug therapy; HIV Infections/virology; HIV-1/drug effects; Adult; Anti-HIV Agents/administration & dosage; Female; HIV Infections/epidemiology; HIV-1/genetics; Humans; Male; Medication Adherence; Middle Aged; Mutation; Rwanda/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents / Drug Resistance, Viral Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Antivir Ther Journal subject: TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 2016 Type: Article Affiliation country: Rwanda

Fulltext

XML

PubMed Links

Search on Google